BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sadremomtaz A, Al-Dahmani ZM, Ruiz-Moreno AJ, Monti A, Wang C, Azad T, Bell JC, Doti N, Velasco-Velázquez MA, de Jong D, de Jonge J, Smit J, Dömling A, van Goor H, Groves MR. Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein. J Med Chem 2021. [PMID: 34328726 DOI: 10.1021/acs.jmedchem.1c00477] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Sidorova MV, Bibilashvili RS, Avdeev DV, Kozhokar US, Palkeeva ME, Ovchinnikov MV, Molokoedov AS, Shirokov DA, Semyonova AV, Uvarova VI, Kulyaev PO, Khvatov EV, Ignatova AA, Feofanov AV, Osolodkin DI, Porozov YB, Kozlovskaya LI, Ishmukhametov AA, Parfyonova YV, Egorov AM. Properties and Activity of Peptide Derivatives of ACE2 Cellular Receptor and Their Interaction with SARS-CoV-2 S Protein Receptor-Binding Domain. Dokl Biochem Biophys 2022;:1-5. [PMID: 36580213 DOI: 10.1134/S1607672922060126] [Reference Citation Analysis]
2 Zhang R, Gao K, Sadremomtaz A, Ruiz-moreno AJ, Monti A, Al-dahmani ZM, Gyau B, Doti N, Groves MR. Identification of Hotspots in Synthetic Peptide Inhibitors of the FOXO4:p53 Interaction.. [DOI: 10.21203/rs.3.rs-2361374/v1] [Reference Citation Analysis]
3 Khan SA, Khan A, Zia K, Shawish I, Barakat A, Ul-haq Z. Cheminformatics-Based Discovery of Potential Chemical Probe Inhibitors of Omicron Spike Protein. IJMS 2022;23:10315. [DOI: 10.3390/ijms231810315] [Reference Citation Analysis]
4 Nepali K, Sharma R, Sharma S, Thakur A, Liou JP. Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal. J Biomed Sci 2022;29:65. [PMID: 36064696 DOI: 10.1186/s12929-022-00847-6] [Reference Citation Analysis]
5 Weißenborn L, Richel E, Hüseman H, Welzer J, Beck S, Schäfer S, Sticht H, Überla K, Eichler J. Smaller, Stronger, More Stable: Peptide Variants of a SARS-CoV-2 Neutralizing Miniprotein. Int J Mol Sci 2022;23:6309. [PMID: 35682988 DOI: 10.3390/ijms23116309] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
6 Lee YJ, Shirkey JD, Park J, Bisht K, Cowan AJ. An Overview of Antiviral Peptides and Rational Biodesign Considerations. BioDesign Research 2022;2022:1-19. [DOI: 10.34133/2022/9898241] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Neamati N. Advances Toward COVID-19 Therapies Special Issue. J Med Chem 2022. [PMID: 35138859 DOI: 10.1021/acs.jmedchem.2c00178] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Chenna A, Khan WH, Dash R, Rathore AS, Goel G. Template-based design of peptides to inhibit SARS-CoV-2 RNA-dependent RNA polymerase complexation.. [DOI: 10.1101/2022.01.24.477502] [Reference Citation Analysis]
9 Fernandez-Fuentes N, Molina R, Oliva B. A Collection of Designed Peptides to Target SARS-CoV-2 Spike RBD-ACE2 Interaction. Int J Mol Sci 2021;22:11627. [PMID: 34769056 DOI: 10.3390/ijms222111627] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]